Renal cancer: new models and approach for personalizing therapy

Abstract Background Clear cell RCC (ccRCC) accounts for approximately 75% of the renal cancer cases. Surgery treatment seems to be the best efficacious approach for the majority of patients. However, a consistent fraction (30%) of cases progress after surgery with curative intent. It is currently la...

Full description

Bibliographic Details
Published in:Journal of Experimental & Clinical Cancer Research
Main Authors: Simona di Martino, Gabriele De Luca, Ludovica Grassi, Giulia Federici, Romina Alfonsi, Michele Signore, Antonio Addario, Laura De Salvo, Federica Francescangeli, Massimo Sanchez, Valentina Tirelli, Giovanni Muto, Isabella Sperduti, Steno Sentinelli, Manuela Costantini, Luca Pasquini, Michele Milella, Mustapha Haoui, Giuseppe Simone, Michele Gallucci, Ruggero De Maria, Désirée Bonci
Format: Article
Language:English
Published: BMC 2018-09-01
Subjects:
Renal cell carcinoma
Patient-derived xenografts
Reverse phase protein array; personalized therapy
Targeted therapy
Online Access:http://link.springer.com/article/10.1186/s13046-018-0874-4

Internet

http://link.springer.com/article/10.1186/s13046-018-0874-4

Similar Items